In previous studies on AD tau, we successfullyused metadynamics to identify high potential binding sites that cannotbe found by molecular docking.31,38 In the present study,we followed the methodology of metadynamics for finding the bindingsites of the fibril with new settings of collective variables. The gene discussed is MAPT; the disease is Alzheimer disease.